These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1548 related articles for article (PubMed ID: 29842849)

  • 1. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics on human Toll-like receptor 4 complexation to MD-2: the coreceptor stabilizing function.
    de Aguiar C; Costa MG; Verli H
    Proteins; 2015 Feb; 83(2):373-82. PubMed ID: 25488602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two modes of ligand recognition by TLRs.
    Brodsky I; Medzhitov R
    Cell; 2007 Sep; 130(6):979-81. PubMed ID: 17889640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effect of procyanidin B1 on LPS-treated THP1 cells via interaction with the TLR4-MD-2 heterodimer and p38 MAPK and NF-κB signaling.
    Xing J; Li R; Li N; Zhang J; Li Y; Gong P; Gao D; Liu H; Zhang Y
    Mol Cell Biochem; 2015 Sep; 407(1-2):89-95. PubMed ID: 26037075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies.
    Omotuyi O; Matsunaga H; Ueda H
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S223-9. PubMed ID: 25604147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
    Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
    Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Thermodynamic Funnel Drives Bacterial Lipopolysaccharide Transfer in the TLR4 Pathway.
    Huber RG; Berglund NA; Kargas V; Marzinek JK; Holdbrook DA; Khalid S; Piggot TJ; Schmidtchen A; Bond PJ
    Structure; 2018 Aug; 26(8):1151-1161.e4. PubMed ID: 29779787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis for endotoxin-induced allosteric regulation of the Toll-like receptor 4 (TLR4) innate immune receptor.
    Paramo T; Piggot TJ; Bryant CE; Bond PJ
    J Biol Chem; 2013 Dec; 288(51):36215-25. PubMed ID: 24178299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergosta-7, 9 (11), 22-trien-3β-ol Interferes with LPS Docking to LBP, CD14, and TLR4/MD-2 Co-Receptors to Attenuate the NF-κB Inflammatory Pathway
    Hsieh WT; Hsu MH; Lin WJ; Xiao YC; Lyu PC; Liu YC; Lin WY; Kuo YH; Chung JG
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
    Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
    Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS/TLR4 complex in silico.
    Mobarak E; Håversen L; Manna M; Rutberg M; Levin M; Perkins R; Rog T; Vattulainen I; Borén J
    Sci Rep; 2018 Sep; 8(1):13600. PubMed ID: 30206272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disaccharide-Based Anionic Amphiphiles as Potent Inhibitors of Lipopolysaccharide-Induced Inflammation.
    Borio A; Holgado A; Garate JA; Beyaert R; Heine H; Zamyatina A
    ChemMedChem; 2018 Nov; 13(21):2317-2331. PubMed ID: 30276970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer.
    Mishra V; Pathak C
    Int J Biol Macromol; 2019 Feb; 122():425-451. PubMed ID: 30365988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists.
    Zhang X; Cui F; Chen H; Zhang T; Yang K; Wang Y; Jiang Z; Rice KC; Watkins LR; Hutchinson MR; Li Y; Peng Y; Wang X
    J Chem Inf Model; 2018 Apr; 58(4):816-825. PubMed ID: 29518316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of toll-like receptor 4. Insights from x-ray crystallography and molecular modeling.
    Klett J; Reeves J; Oberhauser N; Pérez-Regidor L; Martín-Santamaria S
    Curr Top Med Chem; 2014; 14(23):2672-83. PubMed ID: 25515751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses.
    Barata TS; Teo I; Brocchini S; Zloh M; Shaunak S
    PLoS Comput Biol; 2011 Jun; 7(6):e1002095. PubMed ID: 21738462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening.
    Švajger U; Brus B; Turk S; Sova M; Hodnik V; Anderluh G; Gobec S
    Eur J Med Chem; 2013; 70():393-9. PubMed ID: 24177366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.